Rich-Henry Schabowsky

Most-cited papers

1. Ex Vivo Expansion of CD4+CD25+FoxP3+ T Regulatory Cells Based on Synergy between IL-2 and 4-1BB Signaling1

   Kutlu G. Elpek, E. Yolcu, Deanna D. H. Franke, C. Lacelle +2 more

   2007Journal of Immunology107 citations Open access

   Semantic Scholar

   Save

2. Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BBL eradicates established tumors

   R. Sharma, Kutlu G. Elpek, E. Yolcu, Rich-Henry Schabowsky +3 more

   2009Cancer Research89 citations Open access

   Semantic Scholar

   Save

3. Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.

   Rich-Henry Schabowsky, Shravan Madireddi, Rajesh Sharma, E. Yolcu +1 more

   2007Current opinion in investigational drugs70 citations

   Semantic Scholar

   Save

4. 4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines

   R. Sharma, Rich-Henry Schabowsky, A. Srivastava, Kutlu G. Elpek +7 more

   2010Cancer Research65 citations Open access

   Semantic Scholar

   Save

5. A Novel Form of 4-1BBL Has Better Immunomodulatory Activity than an Agonistic Anti-4-1BB Ab without Ab Associated Severe Toxicity

   Rich-Henry Schabowsky, Kutlu G. Elpek, Shravan Madireddi, R. Sharma +6 more

   2009Vaccine64 citations Open access

   Semantic Scholar

   Save

6. SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4+ T Cells into CD4+FoxP3+ T Regulatory Cells by Production of IFN-γ

   Shravan Madireddi, Rich-Henry Schabowsky, A. Srivastava, R. Sharma +2 more

   2012PLoS ONE42 citations Open access

   Semantic Scholar

   Save

7. SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model

   R. Sharma, A. Srivastava, E. Yolcu, Kathryn J Macleod +3 more

   2010Vaccine42 citations Open access

   Semantic Scholar

   Save

8. ProtEx™ technology for the generation of novel therapeutic cancer vaccines

   Rich-Henry Schabowsky, R. Sharma, Shravan Madireddi, A. Srivastava +2 more

   2009Experimental and molecular pathology (Print)10 citations Open access

   Semantic Scholar

   Save

9. Correction: SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4+ T Cells into CD4+FoxP3+ T Regulatory Cells by Production of IFN-γ

   Shravan Madireddi, Rich-Henry Schabowsky, A. Srivastava, R. Sharma +2 more

   2012PLoS ONE4 citations Open access

   Semantic Scholar

   Save

10. Abstract 2416: SA-4-1BBL costimulatory ligand as an immune modulator and effective vehicle to deliver antigens into dendritic cells for the generation of robust therapeutic antitumor immune responses

    R. Sharma, Rich-Henry Schabowsky, A. Srivastava, E. Yolcu +4 more

    20101 citations

    Semantic Scholar

    Save

11. SA-4-1BBL serves as an effective immunostimulatory component of HPV-16 E7 protein based therapeutic vaccine in a mouse model of cervical cancer (131.21)

    R. Sharma, A. Srivastava, E. Yolcu, Rich-Henry Schabowsky +1 more

    2010Journal of Immunology1 citations

    Semantic Scholar

    Save

12. A novel form of 4-1BBL demonstrates better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab associated severe toxicity (41.4)

    Rich-Henry Schabowsky, Kutlu G. Elpek, Shravan Madireddi, Rajesh Sharma +4 more

    2009Journal of Immunology1 citations

    Semantic Scholar

    Save

13. SA-4-1BBL as an immune modulator and vehicle to deliver antigens into dendritic cells for effective cancer immunotherapy (144.25)

    Rajesh Sharma, Rich-Henry Schabowsky, A. Srivastava, E. Yolcu +4 more

    2010Journal of Immunology0 citations

    Semantic Scholar

    Save

14. SA-4-1BBL Serves as an Immune Modulator as well as Vehicle to Deliver Antigens into Dendritic Cells in vivo for Generation of Robust Immunity for Eradication of Tumors

    R. Sharma, Rich-Henry Schabowsky, A. Srivastava, E. Yolcu +4 more

    20100 citations

    Semantic Scholar

    Save

15. A novel form of 4-1BB ligand has better efficacy than agonistic 4-1BB antibody as well as TLR agonists in a peptide based cancer vaccine (41.5)

    R. Sharma, Kutlu G. Elpek, E. Yolcu, Rich-Henry Schabowsky +3 more

    2009Journal of Immunology0 citations

    Semantic Scholar

    Save

16. Su.60. A Novel Vaccine Concept for Treatment of Cervical Cancer

    R. Sharma, Kutlu G. Elpek, E. Yolcu, Rich-Henry Schabowsky +3 more

    20080 citations

    Semantic Scholar

    Save

17. IL-2 and 4-1BB Signaling Regulatory Cells Based on Synergy between T + FoxP3+ CD25+ Ex Vivo Expansion of CD4

    Shirwan Chantale Lacelle, Rich-Henry Schabowsky, Haval Kutlu, G. Elpek +2 more

    20070 citations

    Semantic Scholar

    Save